In oncology, understanding the mechanisms behind the spread of cancer cells through blood and lymphatic vessels is crucial ...

A promising breakthrough in the fight against cancer emerges from Russia. The cancer vaccine developed by the Gamaleya Center ...

The US Food and Drug Administration (FDA) has approved Unloxcyt (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are ...

Checkpoint Therapeutics' Unloxcyt wins FDA approval for advanced cSCC, marking the company's entry into the U.S. market, valued over $1 billion annually.

PLEK2 has been found to promote the progression and metastasis of some tumors, but its role in UVM has not yet been reported. Through this study, we hope to explore the effect of PLEK2 on the ...

Indoor tanning exposure was not found to be correlated with melanoma tumor mutational burden, unlike age, nonmelanoma skin ...

The Food and Drug Administration (FDA) has approved Unloxcyt (cosibelimab-ipdl) for patients with locally advanced or ...